Twist Bioscience (TWST) Revenue Growth

Price: $38.94
Market Cap: $2.32B
Avg Volume: 983.26K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 2.146
52W Range: $27.41-60.9
Website: Twist Bioscience

What is Twist Bioscience's Revenue Growth?

  • Twist Bioscience's annual revenue growth as of FY 2024 is 27.69%.
  • Twist Bioscience's quarterly revenue growth as of Q1 2025 is 4.73%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Twist Bioscience's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $312.97M
    • Quarterly: $88.71M
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $179.62M
    • Quarterly: $45.87M
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: 15.60%
    • Quarterly Growth: -1.30%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $133.35M
    • Quarterly: $42.84M
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: 48.61%
    • Quarterly Growth: 12.05%

These metrics provide insights into Twist Bioscience's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

27.69%

Quarterly Revenue Growth

4.73%

Historical Annual Revenue Growth
400.00%400.00%300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%Revenue Growth (Annual)201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue Growth
14.20%14.20%10.95%10.95%7.69%7.69%4.43%4.43%1.17%1.17%-2.09%-2.09%-5.34%-5.34%Revenue Growth (Quarterly)20232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Annual Revenue
$320.00M$320.00M$240.00M$240.00M$160.00M$160.00M$80.00M$80.00M$0.00$0.00Revenue (Annual)201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue
$100.00M$100.00M$80.00M$80.00M$60.00M$60.00M$40.00M$40.00M$20.00M$20.00M$0.00$0.00Revenue (Quarterly)2018201820192019202020202021202120222022202320232024202420252025
Historical Annual Cost of Revenue
$200.00M$200.00M$160.00M$160.00M$120.00M$120.00M$80.00M$80.00M$40.00M$40.00M$0.00$0.00Cost of Revenue (Annual)201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Cost of Revenue
$50.00M$50.00M$40.00M$40.00M$30.00M$30.00M$20.00M$20.00M$10.00M$10.00M$0.00$0.00Cost of Revenue (Quarterly)2018201820192019202020202021202120222022202320232024202420252025
Historical Annual Gross Profit
$160.00M$160.00M$120.00M$120.00M$80.00M$80.00M$40.00M$40.00M$0.00$0.00-$40.00M-$40.00MGross Profit (Annual)201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Gross Profit
$50.00M$50.00M$40.00M$40.00M$30.00M$30.00M$20.00M$20.00M$10.00M$10.00M$0.00$0.00-$10.00M-$10.00MGross Profit (Quarterly)2018201820192019202020202021202120222022202320232024202420252025

Twist Bioscience Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2024 $312.97M 27.69% $179.62M 15.60% $133.35M 48.61%
2023 $245.11M 20.41% $155.38M 30.21% $89.73M 6.52%
2022 $203.56M 53.83% $119.33M 48.02% $84.23M 62.89%
2021 $132.33M 46.87% $80.62M 31.29% $51.71M 80.22%
2020 $90.10M 65.67% $61.41M 29.48% $28.69M 312.33%
2019 $54.38M 113.89% $47.43M 47.34% $6.96M 202.91%
2018 $25.43M 136.16% $32.19M 34.01% $-6.76M 48.98%
2017 $10.77M 374.53% $24.02M 154.96% $-13.25M -85.30%
2016 $2.27M 0.00% $9.42M 0.00% $-7.15M 0.00%

Related Metrics

Explore detailed financial metrics and analysis for TWST.